vs
Side-by-side financial comparison of Atara Biotherapeutics, Inc. (ATRA) and Rigetti Computing, Inc. (RGTI). Click either name above to swap in a different company.
Rigetti Computing, Inc. is the larger business by last-quarter revenue ($1.9M vs $1.6M, roughly 1.2× Atara Biotherapeutics, Inc.). On growth, Rigetti Computing, Inc. posted the faster year-over-year revenue change (-17.9% vs -95.1%). Over the past eight quarters, Rigetti Computing, Inc.'s revenue compounded faster (-21.8% CAGR vs -75.9%).
Atara Biotherapeutics, Inc. is a clinical-stage biotechnology company focused on developing allogeneic T-cell immunotherapies for patients with unmet medical needs across oncology, autoimmune disease, and infectious disease indications. It operates primarily in North America, Europe, and Asia-Pacific, partnering with research institutions to advance its novel treatment pipeline.
Rigetti Computing, Inc. is a Berkeley, California-based developer of superconducting quantum integrated circuits used for quantum computers. Rigetti also develops a cloud platform called Forest that enables programmers to write quantum algorithms.
ATRA vs RGTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.6M | $1.9M |
| Net Profit | — | $-18.2M |
| Gross Margin | — | 34.9% |
| Operating Margin | — | -1209.7% |
| Net Margin | — | -974.7% |
| Revenue YoY | -95.1% | -17.9% |
| Net Profit YoY | 73.2% | 88.1% |
| EPS (diluted) | — | $-0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.6M | $1.9M | ||
| Q3 25 | $3.5M | $1.9M | ||
| Q2 25 | $17.6M | $1.8M | ||
| Q1 25 | $98.1M | $1.5M | ||
| Q4 24 | $32.8M | $2.3M | ||
| Q3 24 | $40.2M | $2.4M | ||
| Q2 24 | $28.6M | $3.1M | ||
| Q1 24 | $27.4M | $3.1M |
| Q4 25 | — | $-18.2M | ||
| Q3 25 | $-4.3M | $-201.0M | ||
| Q2 25 | $2.4M | $-39.7M | ||
| Q1 25 | $38.0M | $42.6M | ||
| Q4 24 | $-12.7M | $-153.0M | ||
| Q3 24 | $-21.9M | $-14.8M | ||
| Q2 24 | $-19.0M | $-12.4M | ||
| Q1 24 | $-31.8M | $-20.8M |
| Q4 25 | — | 34.9% | ||
| Q3 25 | — | 20.7% | ||
| Q2 25 | — | 31.4% | ||
| Q1 25 | — | 30.0% | ||
| Q4 24 | — | 44.1% | ||
| Q3 24 | — | 50.6% | ||
| Q2 24 | — | 64.5% | ||
| Q1 24 | — | 49.1% |
| Q4 25 | — | -1209.7% | ||
| Q3 25 | -103.5% | -1055.4% | ||
| Q2 25 | 18.2% | -1103.9% | ||
| Q1 25 | 39.5% | -1469.6% | ||
| Q4 24 | -37.3% | -813.3% | ||
| Q3 24 | -54.1% | -729.4% | ||
| Q2 24 | -63.7% | -521.2% | ||
| Q1 24 | -114.2% | -543.4% |
| Q4 25 | — | -974.7% | ||
| Q3 25 | -124.6% | -10321.9% | ||
| Q2 25 | 13.6% | -2201.8% | ||
| Q1 25 | 38.7% | 2895.3% | ||
| Q4 24 | -38.8% | -6726.5% | ||
| Q3 24 | -54.5% | -623.8% | ||
| Q2 24 | -66.5% | -402.5% | ||
| Q1 24 | -116.1% | -680.6% |
| Q4 25 | — | $-0.08 | ||
| Q3 25 | $-0.32 | $-0.62 | ||
| Q2 25 | $0.19 | $-0.13 | ||
| Q1 25 | $3.50 | $0.13 | ||
| Q4 24 | $0.27 | $-0.80 | ||
| Q3 24 | $-2.93 | $-0.08 | ||
| Q2 24 | $-3.10 | $-0.07 | ||
| Q1 24 | $-5.65 | $-0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.5M | $44.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-38.5M | $546.2M |
| Total Assets | $20.2M | $666.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.5M | $44.9M | ||
| Q3 25 | $13.7M | $26.1M | ||
| Q2 25 | $22.3M | $57.2M | ||
| Q1 25 | $13.8M | $37.2M | ||
| Q4 24 | $42.5M | $67.7M | ||
| Q3 24 | $67.2M | $20.3M | ||
| Q2 24 | $35.3M | $20.7M | ||
| Q1 24 | $46.2M | $35.1M |
| Q4 25 | $-38.5M | $546.2M | ||
| Q3 25 | $-36.6M | $371.8M | ||
| Q2 25 | $-35.0M | $553.3M | ||
| Q1 25 | $-55.1M | $207.1M | ||
| Q4 24 | $-97.3M | $126.6M | ||
| Q3 24 | $-90.5M | $122.8M | ||
| Q2 24 | $-110.9M | $122.2M | ||
| Q1 24 | $-98.3M | $115.6M |
| Q4 25 | $20.2M | $666.6M | ||
| Q3 25 | $30.2M | $630.3M | ||
| Q2 25 | $36.9M | $636.7M | ||
| Q1 25 | $62.0M | $269.1M | ||
| Q4 24 | $109.1M | $284.8M | ||
| Q3 24 | $142.7M | $157.3M | ||
| Q2 24 | $117.3M | $162.4M | ||
| Q1 24 | $165.3M | $162.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-50.9M | $-14.9M |
| Free Cash FlowOCF − Capex | — | $-19.5M |
| FCF MarginFCF / Revenue | — | -1042.5% |
| Capex IntensityCapex / Revenue | 0.0% | 244.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-77.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-50.9M | $-14.9M | ||
| Q3 25 | $-9.8M | $-13.8M | ||
| Q2 25 | $-7.3M | $-16.2M | ||
| Q1 25 | $-28.1M | $-13.7M | ||
| Q4 24 | $-24.5M | $-8.5M | ||
| Q3 24 | $-4.0M | $-15.4M | ||
| Q2 24 | $-10.6M | $-13.5M | ||
| Q1 24 | $-29.6M | $-13.1M |
| Q4 25 | — | $-19.5M | ||
| Q3 25 | — | $-19.7M | ||
| Q2 25 | — | $-21.8M | ||
| Q1 25 | — | $-16.2M | ||
| Q4 24 | $-24.6M | $-9.8M | ||
| Q3 24 | — | $-17.7M | ||
| Q2 24 | $-10.7M | $-15.6M | ||
| Q1 24 | $-29.7M | $-18.6M |
| Q4 25 | — | -1042.5% | ||
| Q3 25 | — | -1012.4% | ||
| Q2 25 | — | -1212.4% | ||
| Q1 25 | — | -1100.4% | ||
| Q4 24 | -75.0% | -432.1% | ||
| Q3 24 | — | -744.5% | ||
| Q2 24 | -37.3% | -504.3% | ||
| Q1 24 | -108.7% | -610.5% |
| Q4 25 | 0.0% | 244.8% | ||
| Q3 25 | 0.0% | 302.5% | ||
| Q2 25 | 0.0% | 314.7% | ||
| Q1 25 | 0.0% | 173.0% | ||
| Q4 24 | 0.3% | 56.4% | ||
| Q3 24 | 0.0% | 95.8% | ||
| Q2 24 | 0.1% | 66.3% | ||
| Q1 24 | 0.5% | 180.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -3.07× | — | ||
| Q1 25 | -0.74× | -0.32× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ATRA
Segment breakdown not available.
RGTI
| Collaborative Research And Other Professional Services | $1.7M | 93% |
| Other | $131.0K | 7% |
